Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA approves Mylan’s generic Advair

The U.S. Food and Drug Administration approved Mylan NV’s generic version of the GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher.

Read More »

J&J, U.S. states settle hip implant claims for $120 million

Johnson & Johnson and the company’s DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over the company’s metal-on-metal hip implants.

Read More »

Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation

Abbott announced U.S. Food and Drug Administration approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib).

Read More »

Abbott To Acquire Cephea Valve Technologies

Abbott exercised an option to purchase Cephea Valve Technologies, a device company developing a less-invasive heart valve replacement technology for mitral valve disease.

Read More »

Edward Lifesciences pays Boston Scientific $180 million to end patent row

Edwards Lifesciences Corp. paid rival Boston Scientific Corp. $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Read More »

FDA Approves World’s First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts

Abbott announced the U.S. Food and Drug Administration approved the Amplatzer Piccolo Occluder, the world’s first medical device that can be implanted in the tiniest babies using a minimally invasive procedure to treat patent ductus arteriosus (PDA).

Read More »

Investing Into R&D Pays off for Some of Biotech’s Biggest Companies

PwC’s annual R&D spending report showcases companies that stand out in the field of biotechnology.

Read More »

GeoVax and Enesi Pharma to Collaborate on Development of Multiple Vaccines

GeoVax Labs and Enesi Pharma announced a collaboration to develop solid-dose needle-free vaccine formulations utilizing GeoVax’s novel MVA-VLP vaccine platform in combination with Enesi’s ImplaVax device and formulation technology.

Read More »

QurAlis Spins out Med Device Company EnClear to Target ALS

EnClear Therapies – a new medical device company spun out from QurAlis – will focus developmental programs on targeting neurological diseases, including amyotrophic lateral sclerosis and progressive supranuclear palsy.

Read More »

Boston Scientific Exercises Option to Buy Millipede

Boston Scientific exercised the company’s option to buy the remaining shares of Santa Rosa, Calif.-based Millipede for $325 million.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!


Ad Right Bottom